Status: current, Defined. Date: 31-Mar 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 465871000036117 | Ksart HCT 300/25 (hydrochlorothiazide 25 mg + irbesartan 300 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 465881000036115 | Ksart HCT 300/25 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ksart HCT 300/25 tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ksart HCT 300/25 tablet | Is a | Ksart HCT 300/25 | true | Inferred relationship | Some | ||
| Ksart HCT 300/25 tablet | Is a | irbesartan 300 mg + hydrochlorothiazide 25 mg tablet | true | Inferred relationship | Some | ||
| Ksart HCT 300/25 tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Ksart HCT 300/25 tablet | has unit of use | tablet | true | Inferred relationship | Some | 1525732287 | |
| Ksart HCT 300/25 tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 1525732286 | |
| Ksart HCT 300/25 tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 1525732286 | |
| Ksart HCT 300/25 tablet | has intended active ingredient | irbesartan | true | Inferred relationship | Some | 637149868 | |
| Ksart HCT 300/25 tablet | has Australian BoSS | irbesartan | true | Inferred relationship | Some | 637149868 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ksart HCT 300/25 tablet, 30 | has TPUU | True | Ksart HCT 300/25 tablet | Inferred relationship | Some | 1 |
| Ksart HCT 300/25 tablet, 30, blister pack | has TPUU | True | Ksart HCT 300/25 tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR